Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Nobel laureate Kariko underscores groundbreaking potential of mRNA technology

STORY: Nobel laureate Kariko underscores groundbreaking potential of mRNA technology DATELINE: Oct. 15, 2023 LENGTH: 00:01:32 LOCATION: SZEGED, Hungary CATEGORY: SCIENCE SHOTLIST: 1. various of the panel discussion STORYLINE: Biochemist Katalin Kariko, 2023 Nobel laureate in physiology or medicine, underscored the application potential of mRNA technology in a panel discussion at her alma mater, University of Szeged, on Thursday evening. Originally focused on cancer vaccines, mRNA's versatility has broadened to encompass various therapeutic applications, particularly in the rapidly evolving field of therapy drugs, she explained to an audience made up mostly of university students in response to a question from Xinhua. "Definitely, the messenger RNA (mRNA) as a therapy will be used for many, many applications, many different treatments, and therapies," she said. "Originally, you know the first ones of these companies such as BioNtech in 2008 were formed to make cancer vaccines, and they gained a lot of kn

E

Kariko, Weissman win Nobel medicine prize for COVID mRNA vaccine work

University of Pennsylvania professor Drew Weissman arrives at the venue of a press conference at the university in Philadelphia, the United States, on Oct. 2, 2023, after being awarded this year's Nobel Prize in physiology or medicine jointly with his Hungarian research partner Katalin Kariko for their work leading to the development of COVID-19 vaccines using a new messenger RNA technology.

E

Kariko, Weissman win Nobel medicine prize for COVID mRNA vaccine work

Hungary's Katalin Kariko (L) and her American research partner Drew Weissman attend a press conference at the University of Pennsylvania in Philadelphia, the United States, on Oct. 2, 2023, after being awarded this year's Nobel Prize in physiology or medicine for their work leading to the development of COVID-19 vaccines using a new messenger RNA technology.

E

Kariko, Weissman win Nobel medicine prize for COVID mRNA vaccine work

Hungarian scientist Katalin Kariko arrives at the venue of a press conference at the University of Pennsylvania in Philadelphia, the United States, on Oct. 2, 2023, after being awarded this year's Nobel Prize in physiology or medicine jointly with her American research partner Drew Weissman for their work leading to the development of COVID-19 vaccines using a new messenger RNA technology.

E

Univ. of Tokyo fires professor, assistant for suspect research

TOKYO, Japan - Junichi Hamada (L), executive vice president at the University of Tokyo, speaks about the dismissal of Professor Kazunari Taira and his assistant Hiroaki Kawasaki at a news conference at the university in Tokyo on Dec. 27. The two are suspected of having fabricated research papers on RNA.

E

Suspicions over professor's results 1st surfaced years ago

TOKYO, Japan - Kazunari Taira (back L), professor at the University of Tokyo, and Hiroaki Kawasaki (back R), his assistant, respond to questions on Jan. 27 from reporters about allegations that their research team fabricated research on RNA.

E

Professor Inoue of University of Tokyo, announce the identification of a new coronavirus drug candidate

Professor Junichiro Inoue and his colleagues at the University of Tokyo's Institute of Medical Science held a press conference on April 18 and announced that they had identified nafamostat. Nafamostat has been used for more than 30 years in Japan, and early clinical trials are expected to be conducted. The clinical research is expected to start by the beginning of April in cooperation with the National Center for Global Health and Medicine and others. When the new corona infects humans, proteins on the surface of the virus and proteins on the surface of human cells bind to each other, causing the outer membrane of the virus to fuse with the membrane of human cells. As a result, ribonucleic acid (RNA), which is the genetic information of the new corona, enters the human cell, and the virus multiplies. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)

E

Kao and PFN collaborate on sebum RNA analysis

On the 20th, Kao announced that it will collaborate with Preferred Networks (PFN, Chiyoda-ku, Tokyo) on the practical application of sebum RNA monitoring technology, which extracts and analyzes ribonucleic acid (RNA) from sebum. Artificial intelligence (AI) technologies such as machine learning and deep learning will be applied to the data obtained from sebum RNA. PFN's AI technology will be incorporated into this technology. Mr. Michitaka Sawada, President of Kao Corporation, said, "Accumulation of data makes prediction possible. "We can expect to use preventive cosmetics to improve the skin in a few years," he said. This technology is also expected to be used in the medical industry. The company is also conducting research with a view to using the technology in the early diagnosis of intractable diseases such as Parkinson's disease. Photo taken on November 19, 2019, credit: Nikkan Kogyo Shimbun / Kyodo News Images

E

Univ. of Tokyo fires professor, assistant for suspect research

TOKYO, Japan - Junichi Hamada (L), executive vice president at the University of Tokyo, speaks about the dismissal of Professor Kazunari Taira and his assistant Hiroaki Kawasaki at a news conference at the university in Tokyo on Dec. 27. The two are suspected of having fabricated research papers on RNA. (Kyodo)